Banka BioLoo returns to profit as September revenue rises

Banka BioLoo Limited returned to a standalone profit of Rs 41.57 lakh for the quarter ended 30 September 2026, compared with a Rs 1.10 crore loss a year earlier, as revenue from operations increased to Rs 16.52 crore from Rs 13.25 crore.

The unaudited standalone results, approved by Banka BioLoo’s board on 12 November 2026, show profit before tax of Rs 49.55 lakh against a pre-tax loss of Rs 1.52 crore in the corresponding quarter of 2025. Banka BioLoo reports one primary operating segment: wastewater and fecal-treatment manufacture, supply, installation and related AMOC services.

How did Banka BioLoo perform in the September 2026 quarter?

Banka BioLoo’s quarterly turnaround reflected higher revenue and a smaller rise in total expenses than in revenue. Revenue from operations rose 24.7% year on year to Rs 16.52 crore in the quarter ended 30 September 2026, while total expenses increased to Rs 16.06 crore from Rs 14.82 crore. Total income, including Rs 41.50 lakh of other income, was Rs 16.56 crore.

The result also improved from the quarter ended 30 June 2026. Revenue increased from Rs 16.36 crore, profit before tax rose from Rs 42.07 lakh, and profit after tax increased from Rs 37.13 lakh. Other income was Rs 41.50 lakh in the September quarter, compared with Rs 41.80 lakh in the preceding quarter.

The quarterly tax expense was Rs 7.98 lakh, compared with a deferred-tax benefit of Rs 11.18 lakh in the September 2025 quarter. Basic earnings per share were Rs 0.38 for September 2026, against a loss per share of Rs 1.01 a year earlier. Banka BioLoo stated that quarterly earnings per share were not annualised.

What changed in Banka BioLoo’s costs and half-year result?

Banka BioLoo reported a six-month profit after tax of Rs 78.70 lakh for the half year ended 30 September 2026, reversing a Rs 96.83 lakh loss in the corresponding half year. Half-year revenue from operations grew to Rs 32.47 crore from Rs 25.81 crore, while total expenses increased to Rs 32.04 crore from Rs 28.41 crore.

Employee-benefit expense declined to Rs 11.91 crore in the first half from Rs 14.57 crore a year earlier, partly offsetting higher material and operating costs. Cost of materials consumed rose to Rs 10.26 crore from Rs 7.22 crore, while operating expenses increased to Rs 5.99 crore from Rs 2.77 crore. Finance costs declined to Rs 1.20 crore from Rs 1.24 crore.

In the September quarter alone, employee-benefit expense was Rs 5.98 crore, below Rs 7.20 crore a year earlier. Operating expenses were Rs 4.05 crore, compared with Rs 1.15 crore in the prior-year quarter, while materials consumed fell to Rs 3.70 crore from Rs 4.19 crore. These movements left total income above expenses by Rs 49.55 lakh before tax.

Depreciation and amortisation were Rs 96.09 lakh for the six months ended 30 September 2026, up from Rs 89.12 lakh in the comparable period. Banka BioLoo reported no exceptional item for the half year, whereas the year ended 31 March 2026 included an exceptional item of Rs 29.52 lakh and closed with profit after tax of Rs 38.21 lakh.

What do Banka BioLoo’s balance sheet and cash position show?

Banka BioLoo’s total standalone assets stood at Rs 75.74 crore on 30 September 2026, up from Rs 73.93 crore on 31 March 2026. Total equity increased to Rs 34.63 crore from Rs 33.59 crore, while current liabilities fell to Rs 34.38 crore from Rs 36.82 crore over the same period.

Trade receivables increased to Rs 26.00 crore at 30 September from Rs 25.67 crore at 31 March. Cash and cash equivalents declined to Rs 3.70 crore from Rs 5.86 crore, while other financial assets rose to Rs 18.11 crore from Rs 15.99 crore. Inventories decreased to Rs 5.92 crore from Rs 6.14 crore.

Current borrowings decreased by Rs 2.63 crore from 31 March, while non-current borrowings rose by Rs 3.17 crore. The half-year cash-flow statement reported cash and cash equivalents of Rs 3.70 crore at the end of September 2026, compared with Rs 5.86 crore at the beginning of the financial year.

What receivables issue did Banka BioLoo disclose?

Banka BioLoo disclosed Rs 7.71 crore of trade receivables, including unbilled revenue, due from the Commissioner and Director of Municipal Administration and Swachha Andhra Corporation. Banka BioLoo has made no provision against these balances and said management expects to recover present and future dues related to the projects.

Management said it is executing the projects to comply with contractual execution terms and to demonstrate that it was not at fault in execution. Its stated recovery expectation is based on contractual terms, internal assessments and discussions with the authority, as well as a favourable interim order from the Hon’ble High Court of Telangana.

The independent auditor highlighted the Rs 7.71 crore receivable in an emphasis-of-matter paragraph but did not modify its review conclusion. The auditor said the review, conducted under the applicable standard for interim financial information, provides moderate assurance rather than the assurance provided by an audit.

Conclusion

Banka BioLoo’s September-quarter standalone result marked a return to profitability, with Rs 41.57 lakh of profit after tax following a Rs 1.10 crore loss a year earlier. Revenue growth to Rs 16.52 crore and lower employee-benefit expense relative to the prior-year quarter helped offset higher operating expenses, while the half-year result also moved to a Rs 78.70 lakh profit.

The disclosed matter to watch is the recovery of Rs 7.71 crore in government-body receivables, for which Banka BioLoo has not recorded a provision. Management’s recovery expectation rests on project execution, contractual terms, discussions with the authorities and the Telangana High Court’s interim order, making subsequent collection progress relevant to the balance sheet and cash position.